%D9%84%D9%8A%D9%81%D9%84%D9%88%D9%86%D9%88%D9%85%D9%8A%D8%AFLefflwnomidLeflunomidLeflunomideLeflunomida%D9%84%D9%81%D9%84%D9%88%D9%86%D9%88%D9%85%D8%A7%DB%8C%D8%AFLeflunomide%E3%83%AC%E3%83%95%E3%83%AB%E3%83%8E%E3%83%9F%E3%83%89%D0%9B%D0%B5%D1%84%D0%BB%D1%83%D0%BD%D0%BE%D0%BC%D0%B8%D0%B4LeflunomideLeflunomidLeflunomid%C4%83%D0%9B%D0%B5%D1%84%D0%BB%D1%83%D0%BD%D0%BE%D0%BC%D0%B8%D0%B4LeflunomidLeflunomidLeflunomid%D0%9B%D0%B5%D1%84%D0%BB%D1%83%D0%BD%D0%BE%D0%BC%D1%96%D0%B4Q248550
about
P1855
Leflunomide in Systemic Lupus ErythematosusObjective Study in Rheumatoid ArthritisStudy Comparing Etanercept With Usual DMARD Therapy in Subjects With Rheumatoid Arthritis in the Asia Pacific RegionCOBRA-Slim With or Without Fast Access to TNF Blockade for Remission Induction in Early RASevere Psoriatic Arthritis - Early intervEntion to Control Disease: the SPEED TrialLeflunomide Treatment for IgG4-RDA Phase I/II Trial of Leflunomide in Previously Treated Metastatic Triple Negative CancersMitoxantrone and Prednisone With or Without Leflunomide in Treating Patients With Stage IV Prostate CancerSU-101 Compared With Procarbazine in Treating Patients With Glioblastoma MultiformeA Study to Compare the Efficacy and Safety of Tacrolimus Capsules With Leflunomide Tablets in Lupus Nephritis PatientsClinical Efficacy and Safety of Leflunomide in Egyptian Patients With Active Rheumatoid ArthritisEffect of Sarilumab on Patient-reported Outcomes in Patients With Active Rheumatoid ArthritisThe Registry Study of Takayasu Arteritis in East ChinaPsoriatic Oligoarthritis Intervention With Symptomatic thErapyLeflunomide in Mild COVID-19 PatientsLeflunomide for the Treatment of High-Risk Smoldering Multiple Myeloma
P4844
Leflunomide: mode of action in the treatment of rheumatoid arthritisThe active metabolite of leflunomide, A77 1726, interferes with dendritic cell functionClinical pharmacokinetics of leflunomideLeflunomide: new antirheumatic drug. Effect on pregnancy outcomesDisruption of the interaction of T cells with antigen-presenting cells by the active leflunomide metabolite teriflunomide: Involvement of impaired integrin activation and immunologic synapse formationSimultaneous determination of leflunomide and its active metabolite, A77 1726, in human plasma by high-performance liquid chromatography.Leflunomide, a novel immunomodulator for the treatment of active rheumatoid arthritis.The Saccharomyces cerevisiae MLF6/YPL244C gene, which encodes a possible yeast homologue of mammalian UDP-galactose transporter, confers resistance to the immunosuppressive drug, leflunomide.[Leflunomide in the treatment of rheumatoid arthritis].Severe atopic dermatitis and leflunomide: first clinical experience and highlights of pertinent experimental data.Leflunomide and methotrexate.Experiences with leflunomide in solid organ transplantation.Tailoring immunosuppressive therapy in interstitial lung diseases.Effectiveness and safety profile of leflunomide in rheumatoid arthritis: actual practice compared with clinical trials.Leflunomide: long-term clinical experience and new uses.Leflunomide in psoriatic arthritis.The potential of newer immunomodulating drugs in the treatment of uveitis: a review.Leflunomide use and the risk of interstitial lung disease in rheumatoid arthritis.Interleukin-13 augments bronchial smooth muscle contractility with an up-regulation of RhoA protein.Inhibition of human cytomegalovirus signaling and replication by the immunosuppressant FK778.Anti-Jo-1 antibody positive polymyositis--successful therapy with leflunomide.Regulation of ultraviolet B-induced phosphorylation of histone H3 at serine 10 by Fyn kinase.Immunosuppression preventing concordant xenogeneic islet graft rejection is not sufficient to prevent recurrence of autoimmune diabetes in nonobese diabetic mice.Leflunomide: is a new oral agent in treatment of acute pancreatitis?Microarray analysis of Leflunomide-induced limb malformations in CD-1 mice.Leflunomide therapy for polyomavirus-induced allograft nephropathy: efficient BK virus elimination without increased risk of rejection.[Leflunomide--the first specific disease-modifying drug against rheumatoid arthritis]Suppression of experimental autoimmune neuritis by leflunomide.Inhibition of angiogenesis-related endothelial activity by the experimental immunosuppressive agent leflunomide.[Leflunomide--a new disease modifying anti-rheumatic agent].[Leflunomide in systemic lupus erythematosus].Treatment of refractory CMV-infection following hematopoietic stem cell transplantation with the combination of foscarnet and leflunomide.New antirheumatic drugs: any real added value? A critical overview of regulatory criteria for their marketing approval.The active metabolite of leflunomide, an immunosuppressive agent, reduces mechanical sensitivity in a rat mononeuropathy model.Additive effects of leflunomide and tacrolimus in prevention of islet xenograft rejection.Leflunomide for chronic sarcoidosis.Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical trial.Leflunomide as a novel treatment option in severe atopic dermatitis.CPEC induces erythroid differentiation of human myeloid leukemia K562 cells through CTP depletion and p38 MAP kinase.Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infection.
P921
description
Arzneistoff
@de
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Leflunomid
@de
Leflunomid
@sh
Leflunomid
@sl
Leflunomid
@sr
Leflunomide
@it
Leflunomide
@nl
Leflunomide
@vi
Leflunomidă
@ro
lefflwnomid
@cy
leflunomid
@nn
type
label
Leflunomid
@de
Leflunomid
@sh
Leflunomid
@sl
Leflunomid
@sr
Leflunomide
@it
Leflunomide
@nl
Leflunomide
@vi
Leflunomidă
@ro
lefflwnomid
@cy
leflunomid
@nn
altLabel
5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide
@cy
5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide
@en
5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide
@cy
5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide
@en
Arabloc®
@cy
Arabloc®
@en
Arava®
@cy
Arava®
@en
HWA 486
@cy
HWA 486
@en
prefLabel
Leflunomid
@de
Leflunomid
@sh
Leflunomid
@sl
Leflunomid
@sr
Leflunomide
@it
Leflunomide
@nl
Leflunomide
@vi
Leflunomidă
@ro
lefflwnomid
@cy
leflunomid
@nn